Patent details

EP2621476 Title: ENTERIC COATED, LOW-STRENGTH PANCRELIPASE FORMULATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2621476
WO Application Number:
IB2011002419
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11788223.3
WO Publication Number:
WO2012042372
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Ireland (IE)
Publications:

Dates

Filing date:
30/09/2011
Grant date:
30/07/2014
EP Publication Date:
07/08/2013
WO Publication Date:
05/04/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
15/10/2020
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
30/07/2014
EP B1 Publication Date:
30/07/2014
EP B2 Publication Date:
22/07/2020
EP B3 Publication Date:
Description Translation B1 Received Date:
13/10/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/09/2031
Lapsed By Expiration Date:
Patent Validated Date:
31/10/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/10/2020
 
 

 

Name:
Société des Produits Nestlé S.A.
Address:
Avenue Nestlé 55, 1800, Vevey, Switzerland (CH)

Historical Applicant/holder

From:
09/07/2020
To:
28/10/2020

 

Name:
Allergan Therapeutics LLC
Address:
5 Giralda Farms, 07940, Madison, NJ, United States of America (US)

From:
15/02/2019
To:
09/07/2020

 

Name:
Allergan Pharmaceuticals International Limited
Address:
Clonshaugh Business & Technology Park, Dublin 17, D17 E400, Ireland (IE)

From:
30/07/2014
To:
15/02/2019

 

Name:
Aptalis Pharma Limited
Address:
The Yard House Killruddery Estate Southern Cross Road, BRAY, COUNTY WICKLOW, Ireland (IE)

Agent

Name:
ir. F.A. Geurts c.s.
From:
30/10/2020
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
30/07/2014
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
29/10/2020

Inventor

1

Name:
ORTENZI, Giovanni
Address:
I-20052 Monza, Italy (IT)

2

Name:
DE FRANZA, Giuseppe
Address:
20060 Pessnao con Bornago, Milano, Italy (IT)

3

Name:
CLEMENTI, Danilo
Address:
24068 Seriate -BG, Italy (IT)

4

Name:
STOLLBERG, Christian
Address:
I-20061 Carugate (MI), Italy (IT)

5

Name:
BOLTRI, Luigi
Address:
I-20041 Agrate Brianza (MB), Italy (IT)

Priority

Priority Patent Number:
389037 P
Priority Date:
01/10/2010
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/20; A61K 9/28; A61K 38/43;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
47/20
Publication date:
18/11/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP5
Journal edition number:
45/20
Publication date:
04/11/2020
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

3

Bulletin Heading:
CO
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP4
Journal edition number:
30/20
Publication date:
22/07/2020
Description:
European patents granted in amended form for the Netherlands

5

Bulletin Heading:
MED
Journal edition number:
30/20
Publication date:
22/07/2020
Description:
Other communications

6

Bulletin Heading:
CO
Journal edition number:
17/19
Publication date:
24/04/2019
Description:
Changes in the Netherlands Patent Register

7

Bulletin Heading:
VB1
Journal edition number:
2015/25
Publication date:
17/06/2015
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

8

Bulletin Heading:
EP3
Journal edition number:
2014/47
Publication date:
19/11/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

9

Bulletin Heading:
EP2
Journal edition number:
2014/32
Publication date:
06/08/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202052
Publication date:
23/12/2020
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
202030
Publication date:
22/07/2020
Description:
Patent maintained (B2 publication)

3

Issue number:
201524
Publication date:
10/06/2015
Description:
Opposition procedure started

4

Issue number:
201431
Publication date:
30/07/2014
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202002123A
Date Registered:
28/10/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Société des Produits Nestlé S.A.
Address:
Avenue Nestlé 55, 1800, Vevey, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001287A
Date Registered:
09/07/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Allergan Therapeutics LLC
Address:
5 Giralda Farms, 07940, Madison, NJ, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201900285A
Date Registered:
15/02/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Allergan Pharmaceuticals International Limited
Address:
Clonshaugh Business & Technology Park, Dublin 17, D17 E400, Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2026
Annual Fee Number:
16
Annual Fee Amount:
1000 Euro
Last Annual Payment Date:
14/08/2025
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
900 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
30/10/2020 Outgoing Correspondence Letter no formal defects 1 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_3_375744l271.pdf
15/10/2020 Claims First filed claims 3 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_2_claims20201015121544562.pdf
07/11/2014 Outgoing Correspondence Outgoing Letter 1 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_6_outgoingcorrespondence20141107.pdf
13/10/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_0_incomingcorrespondencepaper20141013.pdf
13/10/2014 Outgoing Correspondence Outgoing Letter 1 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_1_outgoingcorrespondence20141013.pdf
13/10/2014 Claims Translated claims 3 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_4_claims20141013.pdf
11/08/2014 Incoming Correspondence Paper Correspondence address details 1 PDF /3/2/2/8/8/0511788223/docs/ep11788223.3_5_incomingcorrespondencepaper20140811.pdf